Navigation Links
Blood vessel inhibitor shows promise against metastatic thyroid cancer
Date:7/2/2008

HOUSTON - Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.

The investigational drug, motesanib diphosphate, is a VEGF inhibitor, a biologic agent that targets receptors on a protein known as vascular endothelial growth factor (VEGF). VEGF is instrumental in angiogenesis (formation of new blood vessels), a process that allows tumors to grow and spread.

Study lead author Steven I. Sherman, M.D., chair and professor of M. D. Anderson's Department of Endocrine Neoplasia and Hormonal Disorders, noted strong evidence that VEGF receptors play an important role in metastatic thyroid cancer, a disease with few treatment options.

"There is no standard accepted chemotherapy for advanced metastatic differentiated thyroid cancer, and response rates have typically been 25 percent or less," Sherman said. "Most patients are not treated with systemic chemotherapy because the limited benefit rarely justifies the side effects. Treatment of thyroid cancer has been a completely unmet need."

Sherman, colleagues in 10 countries, and scientists from Amgen, which is developing motesanib diphosphate (AMG 706), planned and conducted one of the largest clinical trials ever done for metastatic thyroid cancer.

Of the 93 patients with rapidly progressing cancer who were enrolled in the study, 49 percent had a positive response. From that group 14 percent had their tumors shrink and 35 percent had their tumors stabilize for more than 24 weeks. Median progression-free survival was estimated to be 40 weeks.

Genetic analyses of 25 patients indicated that those with a specific mutation known as BRAF V600E in their tumors had a better
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood vessel inhibitor shows promise against metastatic thyroid cancer
Blood vessel inhibitor shows promise against metastatic thyroid cancer
(Date:11/27/2009)...alth™ announced today that Spectrum Health (... Enterprise orthopedic templating solution and its... (PRWEB) November 27, 2009 -- Voyant ... (Grand Rapids, Michigan) has licensed its TraumaC...ts TraumaCad Extend workflow solution, to allow it...
(Date:11/26/2009)...-Withcoldandfluseasonuponus,it,smoreimportantthane...ionsandavoidillness. ,, "Weneedtobeproactivenot...llnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(cer...tioncontrolandoccupationalhealthatHospitalforSpeci...lSurgeryhasoneofthelowestinfectionratesofanyhospit...
(Date:11/26/2009)... can lead to strains or worse , , THURSD...ng wrong with stuffing your turkey full to burstin...h your suitcase as you pack for holiday trips. ,...U.S. hospital emergency rooms, doctors, offices, c...lated injuries, such as muscle strains, pulls and ...
(Date:11/26/2009)...Triangle Dental (RTDental), a leading dental group...ed the expansion of its services to include LUMINE...illan. , Durham, NC (P...nounce that Dr. Doug Macmillan, an experienced LU... advanced training seminar. RTDental’s abil...
(Date:11/25/2009)...swire/--TheBartleHallConventionCenterwilltemporari...whenKansasCityhoststhelatestinaseriesofmassivefree...enthasthepotentialtobethebiggestoneyet,becauseitwi...daysinsteadofoveraweekend,"SheriWood,executivedire...heNationalAssociationofFreeClinics(NAFC). ,, At...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2
... addresses health disparities in children; adolesc...tion for Quality Healthcare announced today that i...ity Health Centers, Inc. (MCCHC) in Alexandria, I... children. , , The program focuses on conducting ...
...r Human Rights responds to the publication of a l...e Red Cross which concludes that health profession...et detention centers committed gross violations of... confidential International Committee of the Red C...
... ETS EXPOSURE , Environmental tobacco smoke (ETS) ...n children. However, a new study shows that reduci...iversity of Alabama researchers followed 240 child...ded to caregivers; however, children were given 20...
... of African American employees , , GAITHERSBURG,...xo, a leading integrated food and facilities manag...t who I am as an African American and a woman and ... African American Leadership Forum network group. ...
...he comScore, Inc. February rankings, Health Guru M... growing health site on the web over the last thre...o one of the few health sites with more video view...ruary rankings, Health Guru Media (HealthGuru.com)...
...lp facilitate dialogue,during an eye examination b...Hispanic patients, Transitions Optical has develop...his free bilingual guide illustrates key steps tha...n,critical to making the best possible recommendat...
Other Medicine News:Health News:Centene Foundation for Quality Healthcare Awards Grant to Community Health Center 2Health News:In Wake of ICRC Report, Health Professionals Must Be Held Accountable for Torture 2Health News:In Wake of ICRC Report, Health Professionals Must Be Held Accountable for Torture 3Health News:Journal Chest: April news briefs 2Health News:Sodexo Named as One of the Top Three Companies for African Americans on 2009 DiversityInc Top Ten Companies List 2Health News:Web's Fastest Growing Health Site is a Video Site 2Health News:Web's Fastest Growing Health Site is a Video Site 3Health News:Free Bilingual Eye Exam Guide Now Available to Eyecare Professionals 2Health News:Free Bilingual Eye Exam Guide Now Available to Eyecare Professionals 3
(Date:11/25/2009)...stCall/--ERT(Nasdaq: ERES ),announcedtodaythatDr.M...ithSchneck,theCompany,sExecutiveVicePresidentandCF...HealthCareConferenceat1:30PMESTonDecember1,2009inN...ssthepresentationbyvisitingtheCompany,scorporatewe...essedat http://www.corporate-ir.net/ireye/conflobb...
(Date:11/25/2009)...USNewswire/--RemediumTechnologiesInc.,acompanydeve...g,wonfirstprizeand$10,000intheMostPromisingSecurit...anyofficialsannouncetoday. ,, Selectedfrommoret...hedtheirinventionattheGSCSecuritySummitconferenceh...w.remediumtechnologies.com )isdevelopingahigh-pres...
(Date:11/25/2009)...linker.comannouncesthatanewmarketresearchreportisa...nt-AGlobalMarketPerspective ,, http://www.re...Global-Market-Perspective.html ,, Risingincide...gnationsisaprincipalfactorinfluencinggrowthinthema...reastcancerhasallowedwomentocomeforwardfortheiryea...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Extending treatment after liver transplant may benefit patients with hepatitis C recurrence 60452 1Extending treatment after liver transplant may benefit patients with hepatitis C recurrence 60452 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 1Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 2Toronto Conference Targets the Vitamin D Deficiency Crisis 60448 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 1BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 2BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 3BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 4BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 5BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 6BYETTA Approved for Expanded Use as First Line Treatment for Type 2 Diabetes 14673 7
...tro Assays Show rBChE Suppresses Amyloid Plaque,Fo...ene, Inc., a leading,biodefense company specializi...ical countermeasures against chemical and,biologic...ts,recombinant butyrylcholinesterase (rBChE) resea...ernational Conference on,Alzheimer,s and Parkinson...
...T, N.J., April 04, 2007 /PRNewswire-FirstCall/ -- ...perative Oncology Group,(ECOG) has reported that i...liminary results from a large, randomized clinical...myeloma has found,that the use of a low dose of de...omide suggests survival advantage for,patients whe...
Other Medicine Technology:Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 2ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 3ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 4ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 5ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 6ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03),Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival,Advantage for Patients with Multiple Myeloma 7
...BAK/C cervical interbody fusion system represents ...ive disc disease of the cervical spine. The system...ration, and implantation. The self-packing of bone...raft, eliminating the need to harvest from the ili...
Intera 3.0T
...The Intradiscal Instruments are designed to provid...sc removal, endplate preparation, and insertion of...tebral Spreaders, Intradiscal Wedges, Spanners, Ne...er. Used in ALIF (Anterior Thoracic Interbody Fusi...
...Symphony II Platelet Concentrate System is a point... of Platelet Concentrate (also referred to as Plat...PPP) from a small sample of blood. The Symphony II...s, which are found in the platelets. The platelet ...
Medicine Products: